📰 Industry Classification Benchmark News
Page 2 - Industry Classification Benchmark News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Industry Classification Benchmark. Real-time updates on events, politics, business and more.
May 20, 2024
Ret.en.gb.20240430.GB00B62Z3C74.pdf/465980 FIDELITY INVESTMENT COMPANIES Fidelity China Special Situations PLC ...
May 18, 2024
Meridian Wealth Management LLC cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 50.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,030 shares of the financial services provider’s stock after selling 5,124 shares during the period. […]
May 6, 2024
First Horizon Advisors Inc. boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,193 shares of the financial services provider’s stock after purchasing an additional […]
May 3, 2024
Essex Financial Services Inc. reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,465 shares of the financial services provider’s stock after selling 435 shares during the quarter. […]
April 29, 2024
Investment House LLC cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 68,946 shares of the financial services provider’s stock after selling 2,138 shares during […]
April 25, 2024
Bank of New Hampshire reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 20.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,607 shares of the financial services provider’s stock after selling 914 shares […]
April 25, 2024
Bank of New Hampshire reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 20.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 3,607 shares of the financial services provider’s stock after selling 914 shares during the quarter. Bank of New Hampshire’s holdings in iShares Biotechnology ETF were worth […]
April 24, 2024
SlateStone Wealth LLC lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,356 shares of the financial services provider’s stock after acquiring an additional 906 shares during […]
April 20, 2024
Robbins Farley raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 14.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 25,097 shares of the financial services provider’s stock after purchasing an additional 3,158 shares during the period. iShares Biotechnology […]
April 20, 2024
John G Ullman & Associates Inc. cut its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 38.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,700 shares of the financial services provider’s stock after selling 1,050 shares during the period. John G Ullman & Associates Inc.’s holdings in iShares Biotechnology ETF were […]